RonaldAlanStraussMD

Allergy & Immunology • Fairview Park, OH

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions

Physician

Join to view full profile

Dr. Strauss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Strauss' full profile

Already have an account?

Office
20455 Lorain Rd
Suite T-03
Fairview Park, OH 44126
Phone+1 440-333-2003

Fax+1 440-333-3309

Education & Training

Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1975 - 1976
University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1974 - 1975
The MetroHealth System/Case Western Reserve UniversityResidency, Pediatrics, 1972 - 1974
State University of New York Downstate Medical Center College of MedicineClass of 1972

Certifications & Licensure

OH State Medical License 1975 - 2026
CO State Medical License 1974 - 1978
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

9 citations
The relationship of asthma severity to COVID-19 outcomes.
Joe Zein, Jad Mitri, Jordan M. Bell, Diana Lopez, Ronald A. Strauss
The Journal of Allergy and Clinical Immunology. in Practice. 2021-10-27
20 citations
Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019.
Ronald A. Strauss, Nesreen Jawhari, Amy Attaway, Bo Hu, Lara Jehi
The Journal of Allergy and Clinical Immunology. in Practice. 2021-08-23
16 citations
Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients.
Joe G Zein, Ronald Strauss, Amy H Attaway, Bo Hu, Alex Milinovich
The Journal of Allergy and Clinical Immunology. in Practice. 2022-03-01

Journal Articles

Subcutaneous Terbutaline as an Alternative to Metered-Dose Inhalers for Asthma During the COVID-19 Pandemic
Ronald Strauss, MD, Journal of the American College of Emergency Physicians Open

Press Mentions

Nasal Steroid Sprays Could Be Effective at Preventing Serious Cases of COVID, Study FindsOctober 26th, 2021
Cleveland Clinic Potential Breakthrough: Steroid-Based Nasal Spray Can Significantly Reduce Impact of COVID-19October 1st, 2021
Cleveland Clinic Study Suggests Steroid Nasal Sprays May Help Improve Outcomes in Severe COVID-19 DiseaseSeptember 28th, 2021